Assura Plc (LON:AGR – Get Free Report) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 48.69 ($0.61) and traded as low as GBX 44.40 ($0.56). Assura shares last traded at GBX 44.60 ($0.56), with a volume of 2,171,074 shares changing hands.
Analysts Set New Price Targets
Several equities research analysts have weighed in on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a GBX 56 ($0.71) price target on shares of Assura in a research note on Wednesday, May 24th. Barclays restated an “overweight” rating and set a GBX 57 ($0.72) price objective on shares of Assura in a report on Wednesday, May 24th. Peel Hunt restated a “buy” rating and set a GBX 65 ($0.82) price objective on shares of Assura in a report on Tuesday, May 23rd. Finally, Shore Capital restated a “buy” rating on shares of Assura in a report on Thursday, July 6th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of GBX 60.75 ($0.77).
View Our Latest Stock Report on Assura
Assura Price Performance
Insider Buying and Selling
In related news, insider Jayne Cottam purchased 62,830 shares of the firm’s stock in a transaction that occurred on Friday, June 2nd. The stock was acquired at an average price of GBX 48 ($0.61) per share, for a total transaction of £30,158.40 ($38,016.39). In other Assura news, insider Jonathan Murphy sold 104,817 shares of the company’s stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of GBX 46 ($0.58), for a total value of £48,215.82 ($60,778.80). Also, insider Jayne Cottam acquired 62,830 shares of Assura stock in a transaction on Friday, June 2nd. The stock was acquired at an average price of GBX 48 ($0.61) per share, with a total value of £30,158.40 ($38,016.39). Over the last 90 days, insiders purchased 63,850 shares of company stock worth $3,063,456. 0.24% of the stock is owned by corporate insiders.
Assura Company Profile
Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.
Featured Articles
- Five stocks we like better than Assura
- How to Calculate Return on Investment (ROI)
- 3 Reasons High-Yield Bloomin’ Brands is About to Blossom
- Dividend Payout Ratio Calculator
- 5 Computer Vision Stocks with a Clear Path to Growth
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Reasons Workday Stock Is Setting Up For A New Rally
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.